Search

Author/Creator Small, Eric J

1. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. Issue 2 (February 2015)

Authors:
Ryan, Charles J; Smith, Matthew R; Fizazi, Karim; Saad, Fred; Mulders, Peter F A; Sternberg, Cora N; Miller, Kurt; Logothetis, Christopher J; Shore, Neal D; Small, Eric J; Carles, Joan; Flaig, Thomas W; Taplin, Mary-Ellen; Higano, Celestia S; de Souza, Paul; de Bono, Johann S; Griffin, Thomas W; ...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 2(2015:Feb.)
Page Start:
152
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. Issue 2 (February 2015)

Authors:
Ryan, Charles J; Smith, Matthew R; Fizazi, Karim; Saad, Fred; Mulders, Peter F A; Sternberg, Cora N; Miller, Kurt; Logothetis, Christopher J; Shore, Neal D; Small, Eric J; Carles, Joan; Flaig, Thomas W; Taplin, Mary-Ellen; Higano, Celestia S; de Souza, Paul; de Bono, Johann S; Griffin, Thomas W; ...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 2(2015:Feb.)
Page Start:
152
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel. Issue 2 (29th January 2020)

Authors:
Halabi, Susan; Dutta, Sandipan; Tangen, Catherine M; Rosenthal, Mark; Petrylak, Daniel P; Thompson, Ian M; Chi, Kim N; De Bono, Johann S; Araujo, John C; Logothetis, Christopher; Eisenberger, Mario A; Quinn, David I; Fizazi, Karim; Morris, Michael J; Higano, Celestia S; Tannock, Ian F; Small, Eri...
Journal:
JNCI cancer spectrum
Issue:
Volume 4:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry. (28th March 2022)

Authors:
Borno, Hala T; Kim, Mi-Ok; Hong, Julian C; Yousefi, Sasha; Lin, Amy; Tolstykh, Irina; Zhang, Sylvia; McKay, Rana R; Harismendy, Olivier; Cinar, Pelin; Rugo, Hope; Koshkin, Vadim S; Rabow, Maya; Wang, Christine; Bailey, Adina; Small, Eric J
Journal:
Oncologist
Issue:
Volume 27:Number 5(2022)
Page Start:
398
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial. Issue 10 (October 2018)

Authors:
Saad, Fred; Cella, David; Basch, Ethan; Hadaschik, Boris A; Mainwaring, Paul N; Oudard, Stéphane; Graff, Julie N; McQuarrie, Kelly; Li, Susan; Hudgens, Stacie; Lawson, Joe; Lopez-Gitlitz, Angela; Yu, Margaret K; Smith, Matthew R; Small, Eric J
Journal:
Lancet oncology
Issue:
Volume 19:Issue 10(2018)
Page Start:
1404
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer. Issue 5 (13th May 2021)

Authors:
Sinha, Meenal; Zhang, Li; Subudhi, Sumit; Chen, Brandon; Marquez, Jaqueline; Liu, Eric V; Allaire, Kate; Cheung, Alexander; Ng, Sharon; Nguyen, Christopher; Friedlander, Terence W; Aggarwal, Rahul; Spitzer, Matthew; Allison, James P; Small, Eric J; Sharma, Padmanee; Fong, Lawrence
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor. Issue 5 (12th May 2021)

Authors:
de Kouchkovsky, Ivan; Zhang, Li; Philip, Errol J; Wright, Francis; Kim, Daniel M; Natesan, Divya; Kwon, Daniel; Ho, Hansen; Ho, Son; Chan, Emily; Porten, Sima P; Wong, Anthony C; Desai, Arpita; Huang, Franklin W; Chou, Jonathan; Oh, David Y; Pruthi, Raj S; Fong, Lawrence; Small, Eric J; Friedland...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor. Issue 5 (12th May 2021)

Authors:
de Kouchkovsky, Ivan; Zhang, Li; Philip, Errol J; Wright, Francis; Kim, Daniel M; Natesan, Divya; Kwon, Daniel; Ho, Hansen; Ho, Son; Chan, Emily; Porten, Sima P; Wong, Anthony C; Desai, Arpita; Huang, Franklin W; Chou, Jonathan; Oh, David Y; Pruthi, Raj S; Fong, Lawrence; Small, Eric J; Friedland...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗